Global Orthobiologics Market Outlook 2020 - Research and Markets

May 13, 2016, 05:10 ET from Research and Markets

DUBLIN, May 13, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Orthobiologics Market Outlook 2020" report to their offering. 

     (Logo: )

The orthobiologics market was valued around US$ 4 Billion in 2015. 

The major reason for the growth of the market is the increasing adoption of orthobiologics, especially bone graft substitutes in different orthopedic applications. In addition, rise in the incidence of arthritis and other orthopedic diseases, increase in geriatric population and increase in obesity rate has triggered the growth of this market. However, factors such as high cost of the orthobiologics and orthopedic procedures, complex regulatory framework, and the biocompatibility issues associated with bone morphogenetic proteins are expected to hamper the market growth in the forecasted period. 

In the report the global orthobiologics has been segmented into a market on the basis of product type, application, and geography. Viscosupplementation accounts for the largest share of the orthobiologics products market. Synthetic bone substitutes and stem cell based products are expected to witness a significant growth due to increasing number of research related activities in the stem cell orthobiologics market. Furthermore, the report also provides insights about the orthobiologics products that are in developmental stages. 

Based on applications, the orthobiologics market is divided into spinal fusion, trauma and reconstructive surgery. Spinal fusion accounted for the largest share of the market owing to increasing number of spinal fusion surgeries. The reconstructive surgery market is poised to witness highest growth due to rising number of hip and knee replacement surgeries. 

The market has been divided into four major regions to provide a regional analysis of the orthobiologics market: North America, Europe, Asia, and Rest of the World. Of these, North America is currently the largest market for orthobiologics owing to a high prevalence of obesity and arthritis, and higher healthcare expenditure in the region. The high share is also attributed to the wide acceptance of orthobiologics products, coupled with launch of new and advanced products in the market. The Asian market is poised to witness the highest growth in the forecasted period due to increasing focus of players in this region, and also as a result of an expanding geriatric population base and increasing number of road accidents. 

After an exhaustive study of the industry, the report presents a deep dive competitive landscape covering the top players along with recent developments (new product launches and partnerships, mergers and acquisitions, and joint ventures) and growth strategies adopted by them to sustain their position in the global orthobiologics market. Zimmer Biomet, Medtronic plc, Stryker Corporation, DePuy Synthes, Inc., Smith & Nephew plc, and Wright Medical Group N.V. are some of the leading players in the global orthobiologics market. 

Key Topics Covered: 

1. Analyst View 

2. Research Methodology 

3. Orthobiologics: An Introduction 

4. Market Dynamics 
4.1 Market Drivers 
4.1.1 Growing Geriatric Population 
4.1.2 Surge in the Number of Orthopedic Surgeries 
4.1.3 Rampant Usage of Bone Grafts Substitutes in Various Applications 
4.1.4 Growing Usage of Biologic Solutions in Sports Medicine 
4.1.5 Increasing Acceptance of Orthobiological Products 
4.1.6 Rising Incidence of Obesity and Orthopedic Diseases 
4.1.7 Technological Advancements 
4.2 Market Restraints 
4.2.1 High cost of Orthobiologics and Orthopedic procedures 
4.2.2 Less-Defined Regulatory Environment 
4.2.3 Biocompatibility Issues 
4.2.4 Lack of Clinical Data 
4.3 Market Opportunities 
4.3.1 Rising Orthobiologics Utility in Fracture Healing 
4.3.2 Bone Grafts and Substitutes Offers Significant Growth Opportunity 
4.3.3 High Growth Asian Market 
4.4 Market Trends 
4.4.1 Growing Interest of Venture Capitalist Firms In Orthobiologics 
4.4.2 Rise in Strategic Alliances in Orthobiologics Market 
4.4.3 Soft Tissue Repair: Gaining Momentum 

5. Global Orthobiologics Market Outlook to 2020 

6. Global Orthobiologics Market Size by Product Type 
6.1 Bone Morphogenetic Proteins (BMP) 
6.2 Demineralized Bone Matrix (DBM) 
6.3 Synthetic Bone Substitutes 
6.4 Bone Allografts 
6.5 Stem Cell Therapy 
6.6 Machined Bones 
6.7 Viscosupplementation 

7. Global Orthobiologics Market Size by Applications 
7.1 Spinal Fusion Surgery 
7.2 Reconstructive Surgery 
7.3 Trauma Surgery 

8. Global Orthobiologics Market Size by Geography 
8.1 North America 
8.2 Europe 
8.3 Asia 
8.4 Rest of the World (RoW) 
9. Pipeline Analysis 
10. Competitive Landscape 
11. Key Player Analysis 
11.1 Zimmer Biomet 
11.2 Stryker Corporation 
11.3 DePuy Synthes, Inc. (A Subsidiary of Johnson & Johnson) 
11.4 Medtronic plc 
11.5 Smith & Nephew Plc 
11.6 Orthofix International N.V 
11.7 Wright Medical Group N.V 
11.8 Integra Life Sciences Corporation 
11.9 NuVasive, Inc. 
11.10 Globus Medical, Inc. 

For more information visit

Media Contact:
Laura Wood, Senior Manager    

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets